Latest Breaking News On - Global media relations - Page 6 : comparemela.com

Intrum: Millions to lose sight of spending as monthly subscriptions and payment deferrals pile pressure on household finances

Intrum: Millions to lose sight of spending as monthly subscriptions and payment deferrals pile pressure on household finances
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomRheinland pfalzKristin anderssonAndres rubioGlobal media relations public affairsConsumer payment reportBuy nowPay laterEuropean consumer payment reportGlobal media relationsPublic affairs

Intrum: Millions to lose sight of spending as monthly subscriptions and payment deferrals pile pressure on household fin

STOCKHOLM, Nov. 16, 2023 /PRNewswire/ Millions of consumers across Europe are losing sight of their.

United kingdomKristin anderssonAndres rubioGlobal media relations public affairs directorConsumer payment reportBuy nowPay laterAbout the european consumer payment reportEuropean consumer payment reportGlobal media relationsPublic affairs

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Bylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of pruritus due to this rare genetic condition

France generalUnited kingdomUnited statesJennifer mooreAmy wolfStewart campbellMedison pharmaBinita kamathDara willisIpsen euronextIntrahepatic cholestasisIoana piscociuNicolas boglerGastroenterol hepatolWalter perezInbal chen

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

France generalUnited kingdomUnited statesStewart campbellInbal chenAmy wolfIpsen euronextNicolas boglerBinita kamathIntrahepatic cholestasisMedison pharmaWalter perezJennifer mooreDara willisGastroenterol hepatolIoana piscociu

Ipsen updates on E U Marketing Authorisation Application for odevixibat in Alagille syndrome

Positive opinion from Committee for Medicinal Products for Human Use recommending approval of Bylvay® (odevixibat) based on Phase III ASSERT clinical-trial data in Alagille syndrome (ALGS) already received in July 2023Committee for Orphan Medicinal Products confirms a negative opinion of its review recommending not to maintain the orphan designation for Bylvay in ALGSIpsen plans to submit a new Marketing Authorisation Application for the treatment of ALGS by the end of 2023 under a new brand nam

United statesFrance generalUnited kingdomJennifer mooreIoana piscociuChristelle huguetAmy wolfAsia pacificNicolas boglerIpsen euronextHead of corporate brand strategy communicationsCommittee for orphan medicinal productsCommittee for medicinal products humanEuropean society for pediatric gastroenterology hepatologyHead of researchDevelopment for ipsen